SCHEMBL25055301

SCHEMBL25055301

C[C@H](N)C(=O)N[C@@H](CCCCNC(=O)CNC(=O)CNC(=O)CN)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOD1 Q9Y239 1/20 0.47
▸ SIRT5 Q9NXA8 3/20 0.41
▸ QRFPR Q96P65 5/20 0.40
▸ ALB P02768 1/20 0.40
▸ TLR2 O60603 1/20 0.39
▸ SIRT6 Q8N6T7 1/20 0.37
▸ SIRT1 Q96EB6 1/20 0.37
▸ NMT2 O60551 1/20 0.35
▸ NMT1 P30419 1/20 0.35
▸ ROCK2 O75116 2/20 0.35
▸ PRKACA P17612 1/20 0.35
▸ AKT3 Q9Y243 1/20 0.35
▸ GHSR Q92847 1/20 0.35
▸ GNAI3 P08754 1/20 0.35
▸ GNAO1 P09471 1/20 0.35
▸ GNAI1 P63096 1/20 0.35
▸ NPY4R P50391 3/20 0.34
▸ NPY1R P25929 2/20 0.34
▸ NPY2R P49146 2/20 0.34
▸ NPY5R Q15761 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26426329 0.86 QRFPR (0.42) NOD1SIRT5QRFPRALBTLR2
SCHEMBL16283730 0.81 NOD1 (0.50) NOD1SIRT5ALBTLR2SIRT6
SCHEMBL16285430 0.81 SIRT5 (0.58) NOD1SIRT5ALBTLR2SIRT6
SCHEMBL23618500 0.80 SIRT5 (0.50) SIRT5QRFPRALBTLR2SIRT6
SCHEMBL22674899 0.78 FURIN (0.42) NOD1QRFPRTLR2SIRT6SIRT1
SCHEMBL16283873 0.77 NOD1 (0.47) NOD1SIRT5ALBTLR2SIRT6
SCHEMBL31686179 0.77 NOD1 (0.55) NOD1TLR2SIRT6SIRT1NMT2
SCHEMBL20653679 0.77 NOD1 (0.55) NOD1TLR2SIRT6SIRT1NMT2
SCHEMBL30435754 0.77 NOD1 (0.46) NOD1TLR2SIRT6SIRT1NMT2
SCHEMBL13120896 0.77 ALB (0.49) NOD1SIRT5QRFPRALBTLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11583569-B2 PSMA-targeting amanitin conjugates HEIDELBERG PHARMA RESEARCH GMBH (DE) 2023-02-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11583569-B2 PSMA-targeting amanitin conjugates FOLH1, ANPEP, PSMA6 NOD1 3723/4885SIRT5 2082/4885QRFPR 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback